These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3175252)

  • 1. [Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women].
    Ortega E; Ruiz E; Osorio C
    Rev Esp Fisiol; 1988 Mar; 44(1):13-6. PubMed ID: 3175252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of serum estradiol in postmenopausal women.
    Judd HL; Shamonki IM; Frumar AM; Lagasse LD
    Obstet Gynecol; 1982 Jun; 59(6):680-6. PubMed ID: 7078905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City.
    Carranza-Lira S; Velasco Díaz G; Olivares A; Chán Verdugo R; Herrera J
    Int J Fertil Womens Med; 2006; 51(2):83-8. PubMed ID: 16881384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.
    Rizkallah TH; Tovell HM; Kelly WG
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1045-56. PubMed ID: 1133154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in circulating steroids with aging in postmenopausal women.
    Meldrum DR; Davidson BJ; Tataryn IV; Judd HL
    Obstet Gynecol; 1981 May; 57(5):624-8. PubMed ID: 7219911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.
    MacDonald PC; Edman CD; Hemsell DL; Porter JC; Siiteri PK
    Am J Obstet Gynecol; 1978 Feb; 130(4):448-55. PubMed ID: 629289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women.
    van der Wall E; Donker TH; de Frankrijker E; Nortier HW; Thijssen JH; Blankenstein MA
    Cancer Res; 1993 Oct; 53(19):4563-6. PubMed ID: 8402628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in segmental lean and fat mass components between pre- and postmenopausal women.
    Douchi T; Yonehara Y; Kawamura Y; Kuwahata A; Kuwahata T; Iwamoto I
    Menopause; 2007; 14(5):875-8. PubMed ID: 17429335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, hormones, and cancer.
    Kirschner MA; Ertel N; Schneider G
    Cancer Res; 1981 Sep; 41(9 Pt 2):3711-7. PubMed ID: 7260928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocrine transition around menopause--a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women.
    Overlie I; Moen MH; Morkrid L; Skjaeraasen JS; Holte A
    Acta Obstet Gynecol Scand; 1999 Aug; 78(7):642-7. PubMed ID: 10422913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aging and obesity on aromatase activity of human adipose cells.
    Cleland WH; Mendelson CR; Simpson ER
    J Clin Endocrinol Metab; 1985 Jan; 60(1):174-7. PubMed ID: 3964790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women.
    Frumar AM; Meldrum DR; Geola F; Shamonki IM; Tataryn IV; Deftos LJ; Judd HL
    J Clin Endocrinol Metab; 1980 Jan; 50(1):70-5. PubMed ID: 7350188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen levels in postmenopausal women with hot flashes.
    Erlik Y; Meldrum DR; Judd HL
    Obstet Gynecol; 1982 Apr; 59(4):403-7. PubMed ID: 7078891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women.
    Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY
    Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone.
    Barone RM; Shamonki IM; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1979 Nov; 49(5):672-6. PubMed ID: 489709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulator young women.
    Edman CD; MacDonald PC
    Am J Obstet Gynecol; 1978 Feb; 130(4):456-61. PubMed ID: 629290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of obesity to blood estrogens.
    Zumoff B
    Cancer Res; 1982 Aug; 42(8 Suppl):3289s-3294s. PubMed ID: 7083189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone metabolism: body weight and extraglandular estrogen production.
    Whitworth NS; Meeks GR
    Clin Obstet Gynecol; 1985 Sep; 28(3):580-7. PubMed ID: 4053452
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
    O'Brien SN; Anandjiwala J; Price TM
    Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.